REGN

E579608

REGN is the stock ticker symbol for Regeneron Pharmaceuticals, a major U.S.-based biotechnology company known for developing innovative antibody-based therapies.

All labels observed (2)

Label Occurrences
REGN canonical 3
NASDAQ:REGN 1

How this entity was disambiguated

Statements (45)

Predicate Object
instanceOf stock ticker symbol
associatedWithIndustry biotechnology
associatedWithSector healthcare
country United States
currency USD
linked to: US dollar
exchangeMarket NASDAQ Global Select Market
hasCUSIP 75886F107
hasISIN US75886F1075
hasUnderlyingCompanyBusinessModel research, development, manufacturing, and commercialization of biologic medicines
hasUnderlyingCompanyCEO Leonard S. Schleifer
hasUnderlyingCompanyCoFounder George D. Yancopoulos
Leonard S. Schleifer
hasUnderlyingCompanyCollaboration Sanofi
hasUnderlyingCompanyCOVID19Involvement developed REGEN-COV for COVID-19 treatment
hasUnderlyingCompanyEmployeeType research-intensive workforce
hasUnderlyingCompanyExchangeListing NASDAQ:REGN
linked to: REGN
hasUnderlyingCompanyFocus biopharmaceutical research and development
hasUnderlyingCompanyFoundedYear 1988
hasUnderlyingCompanyHeadquarters Tarrytown, New York, United States
linked to: Tarrytown, New York
hasUnderlyingCompanyIncorporationCountry United States
hasUnderlyingCompanyLegalName Regeneron Pharmaceuticals, Inc.
hasUnderlyingCompanyNotableProduct Dupixent (dupilumab)
linked to: Dupixent

Eylea (aflibercept)
linked to: Eylea

REGEN-COV (casirivimab and imdevimab)
linked to: REGN-COV2
hasUnderlyingCompanyPrimaryBusiness development of antibody-based therapies
hasUnderlyingCompanyRAndDFocus genetics-based drug discovery
monoclonal antibodies
hasUnderlyingCompanyResearchCollaboration Regeneron Genetics Center
hasUnderlyingCompanyStateOfIncorporation New York
hasUnderlyingCompanyStockCategory large-cap biotechnology stock
hasUnderlyingCompanyTechnologyPlatform VelocImmune antibody technology
hasUnderlyingCompanyTherapeuticArea cardiovascular diseases
immunology
oncology
ophthalmology
hasUnderlyingCompanyTicker REGN
hasUnderlyingCompanyType public company
hasUnderlyingCompanyWebsite https://www.regeneron.com
isComponentOfIndex NASDAQ Biotechnology Index (NBI)
S&P 500 Index
listedOn NASDAQ
regulatoryJurisdiction U.S. Securities and Exchange Commission
represents Regeneron Pharmaceuticals, Inc.
securityType common stock
tradedAs REGN

How these facts were elicited

Referenced by (4)

Full triples — surface form annotated when it differs from this entity's canonical label.

REGN hasUnderlyingCompanyExchangeListing NASDAQ:REGN
linked to: REGN
REGN tradedAs REGN